Raquel E. Izumi, Ph.D.
Affiliations: | 2000 | University of California, Los Angeles, Los Angeles, CA |
Area:
Microbiology BiologyGoogle:
"Raquel Izumi"Parents
Sign in to add mentor| Asim Dasgupta | grad student | 2000 | UCLA | |
| (The role of cellular proteins in viral internal ribosome entry segment (IRES) -mediated translation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Frigault MM, Mithal A, Wong H, et al. (2023) Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated Transcription. Cancer Research Communications. 3: 2268-79 |
| Sher S, Whipp E, Walker J, et al. (2022) VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia. Leukemia |
| Dasgupta A, Das S, Izumi R, et al. (2004) Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses. Fems Microbiology Letters. 234: 189-99 |
| Izumi RE, Das S, Barat B, et al. (2004) A peptide from autoantigen La blocks poliovirus and hepatitis C virus cap-independent translation and reveals a single tyrosine critical for La RNA binding and translation stimulation. Journal of Virology. 78: 3763-76 |
| Izumi RE, Valdez B, Banerjee R, et al. (2001) Nucleolin stimulates viral internal ribosome entry site-mediated translation. Virus Research. 76: 17-29 |